Assignee
UBI US HOLDINGS LLC
US·2 granted patents·3 pending applications·0 citations·filing 2014–2025
Top patents by PatentIndex Score
5 records- 0163US2025262286A1Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory responseUBI US HOLDINGS LLC·Filed 2025·Application pending·0 cites
- 0249US11180555B2Antibodies directed against CD4 for the treatment and functional cure of HIVUBI US HOLDINGS LLC·Filed 2014·Granted Nov 23, 2021·0 cites·65 claims
- 0349US2022023400A1Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory responseUBI US HOLDINGS LLC·Filed 2019·Application pending·0 cites
- 0442US11292839B2Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patientsUBI US HOLDINGS LLC·Filed 2017·Granted Apr 5, 2022·0 cites·63 claims
- 0542US2021079054A1Peptide immunogens of il-31 and formulations thereof for the treatment and/or prevention of atopic dermatitisUBI US HOLDINGS LLC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when UBI US HOLDINGS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →